Beyond MGMT, genome-wide studies have identified other genes with frequent promoter methylation in GBM, such as PTEN, RB1, CDKN2A (though the latter two are often deleted rather than methylated), and apoptotic gene promoters. The gene discussed is MGMT; the disease is glioblastoma.